Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | P 37 72 482.7 |
| 96 | EP file number | EAKZ | 87 10 9559.2 |
| 97 | EP publication number | EPN | 254902 |
| 54 | Designation/title | TI | Lösungen von Oxazaphosphorinen mit verbesserter Stabilität und Verfahren zu deren Herstellung. |
| 51 | IPC main class | ICM
(ICMV) | A61K 31/675 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 47/10 (2006.01) |
| 22 | DE application date | DAT | Jul 3, 1987 |
| 96 | EP application date | EAT | Jul 3, 1987 |
| 43 | Date of first publication | OT | Feb 3, 1988 |
| Date of publication of grant | PET | Aug 28, 1991 |
| 71/73 | Applicant/owner | INH | Baxter Healthcare S.A., 8304 Wallisellen, CH; Baxter International Inc., Deerfield, Ill., US |
| 72 | Inventor | IN | Sauerbier, Dieter, W-4806 Werther, DE; Molge Dr., Klaus, W-4800 Bielefeld 14, DE; Weigert Dr., Werner, W-4800 Bielefeld 14, DE; Isaac Dr., Otto, W-6450 Hanau 9, DE |
| 74 | Representative | VTR | Bachmann, Jürgen, Dipl.-Chem. Dr.rer.nat., 01445 Radebeul, DE |
| Address for service | | Baxter Oncology GmbH Patente/G108-F220 z.H. Herrn Dr. Jürgen Bachmann, 60314 Frankfurt, DE |
66
66
| Domestic priority | PRN
PRD
| 3623369
Jul 11, 1986
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | DE - Deutsch |
| 84 | Designated EP contracting states | EDS | AT, BE, CH, DE, ES, FR, GB, GR, IT, LI, LU, NL, SE |
| 43 | Date of first publication | EVT | Feb 3, 1988 |
| Date of the first transfer into DPMAregister | EREGT | Sep 25, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 23, 2015
(Show all update days)(Hide all update days)- Oct 23, 2015; Mar 18, 2015; Jan 19, 2013
- Historical data not available for this/these date(s)
- Sep 25, 2012
- Date of the first transfer into DPMAregister
|
